On September 22, 2026, the Office of the United States Trade Representative will hold a public hearing on the 301 investigation, which addresses German practices, policies and practices relating to pharmaceutical products.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.